Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Richter

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Der Urologe. Ausg. A|September 4, 2009
[Therapy of overactive bladder with propiverine ER: results of a non-interventional study with a propiverine retard formulation and comparison to clinical studies]P L Kessler-Zumpe, S Murgas, G Neumann, et al.
Der Urologe. Ausg. A|March 9, 2005
[Therapy for overactive detrusor using propiverine]S Alloussi, M Goepel, A E Richter, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Der Urologe. Ausg. A|September 4, 2009
[Therapy of overactive bladder with propiverine ER: results of a non-interventional study with a propiverine retard formulation and comparison to clinical studies]P L Kessler-Zumpe, S Murgas, G Neumann, et al.
Der Urologe. Ausg. A|March 9, 2005
[Therapy for overactive detrusor using propiverine]S Alloussi, M Goepel, A E Richter, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Pageof 1